Real-time enrollment status for this autosomal dominant polycystic kidney disease (adpkd) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:48 AM UTC
| NCT Number | NCT07161037 |
| Recruiting Status | Recruiting |
| Condition | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | June 15, 2026 (4 weeks ago) |
As of July 13, 2026: Clinical trial NCT07161037 is currently recruiting participants. This clinical trial study for autosomal dominant polycystic kidney disease (adpkd) is actively seeking new participants at 26 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07161037 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07161037 was last updated 4 weeks ago (June 15, 2026). HelloStudys verifies this status automatically.